Medical Guidelines |
Reason for Update |
Ambulatory Event Monitors |
Minor edits to Description section. Billing/Coding section and References updated. No change to policy statement. Specialty Matched Consultant Advisory Panel review 10/2022. Medical Director review 10/2022. |
Anesthesia Services |
References updated. Specialty Matched Consultant Advisory Panel review 10/2022. Medical Director Review 10/2022. No change to policy statement. |
Baroreflex Stimulation Devices |
Description, Policy Guidelines and References updated. No change to policy statement. Specialty Matched Consultant Advisory Panel review 10/2022. Medical Director review 10/2022. |
Cardiac Monitoring Devices in the Outpatient Setting |
Description, Regulatory Status and References updated. No change to policy statement. Specialty Matched Consultant Advisory Panel review 10/2022. Medical Director review 10/2022. |
Carotid Intimal-Medial Thickness |
Minor edits to Description section for clarity, References updated. No change to policy statement. Specialty Matched Consultant Advisory Panel review 10/2022. Medical Director review 10/2022. |
Computed Tomography to Detect Coronary Artery Calcification |
Policy Guidelines edited for clarity. References updated. No change to policy statement. Specialty Matched Consultant Advisory Panel review 10/2022. Medical Director review 10/2022. |
Dental Criteria for use of Hospital Inpatient or Outpatient Facility Services or Ambulatory Surgery Center Facility Services |
Specialty Matched Consultant Advisory Panel review 10/2022. Medical Director Review 10/2022. No change to policy statement. |
Dental Reconstructive Services |
Added the following statement to When Covered section: “When the procedures are the direct or indirect result of cancer treatments, including chemotherapy, biotherapy, or radiation therapy” to align with HB 646. Typo corrected in Billing/Coding section. Specialty Matched Consultant Advisory Panel review 10/2022. Medical Director Review 10/2022. |
Electronic Brachytherapy for Nonmelanoma Skin Cancer |
Removed CPT codes 77767, 77768 from Billing/Coding section for clarity. Reference added. No change to policy intent/statement. |
Enhanced External Counterpulsation (EECP) |
References updated. Specialty Matched Consultant Advisory Panel review 10/2022. Medical Director review 10/2022. |
Hyperbaric Oxygen Therapy |
Minor updates to policy guidelines. References updated. Specialty Matched Consultant Advisory Panel review 10/2022. Medical Director review 10/2022. No change to policy statement. |
Orthodontics for Pediatric Patients |
Specialty Matched Consultant Advisory Panel review 10/2022. Medical Director Review 10/2022. No change to policy statement. |
Orthognathic Surgery |
Specialty Matched Consultant Advisory Panel review 10/2022. Medical Director Review 10/2022. No change to policy statement. |
Prenatal Screening (Genetic) AHS-M2179 |
Policy title updated to include “AHS-M2179” to align with Avalon. |
Progenitor Cell Therapy for the Treatment of Damaged Myocardium Due to Ischemia |
Description section, Policy Guidelines and References updated. No change to policy statement. Specialty Advisory Consultant Advisory Panel review 10/2022. Medical Director review 10/2022. |
Signal-Averaged ECG |
References updated. Specialty Matched Consultant Advisory Panel review 10/2022. Medical Director review 10/2022. |
Spinal Manipulation Under Anesthesia |
Minor updates made to description. Moved statement related to evidence reviews from When not Covered to Policy Guidelines for clarity. Specialty Matched Consultant Advisory Panel Review 10/2022. Medical Director Review 10/2022. References updated. No change to policy statement. |
Stem-cell Therapy for Peripheral Arterial Disease |
References updated. Specialty Matched Consultant Advisory Panel review 10/2022. Medical Director review 10/2022. |
Temporomandibular Joint Dysfunction (TMJD) |
Minor updates to description for clarity. Regulatory status updated. Related policies added. Policy Guidelines updated. References updated. Specialty Matched Consultant Advisory Panel review 10/2022. Medical Director Review 10/2022. No change to policy statement. |
Wearable Cardioverter Defibrillators |
Description section including Regulatory Status, Policy Guidelines and References updated. No change to policy statement. Specialty Matched Consultant Advisory Panel review 10/2022. Medical Director review 10/2022. |